Pathogenesis, clinical evaluation and treatment of neuropathic cancer pain
10.3760/cma.j.issn.1673-422X.2015.12.017
- VernacularTitle:癌性神经病理性疼痛的发病机制、临床评估及治疗
- Author:
Weishuai LIU
;
Yuejuan SHAO
;
Kun WANG
- Publication Type:Journal Article
- Keywords:
Neoplasms;
Neuralgia;
Diagnosis;
Therapy
- From:
Journal of International Oncology
2015;42(12):946-949
- CountryChina
- Language:Chinese
-
Abstract:
Neuropathic cancer pain (NCP) arises from physical or chemical damage to peripheral or central neurons or in the neural conduction system.The mechanisms of NCP include pain directly related to tumor involvement,pain associated with chemotherapy,radiotherapy and surgery,neuropathic syndromes associated with paraneoplastic syndromes,inflammation and other factors.A detailed history and careful physical examination are important means of diagnosis of NCP.The clinical evaluation of NCP should use standardized pain assessment scale.Till now,the treatments of NCP include opioid combined with auxiliary analgesic drugs,interventional treatment and gene treatment.Deciding treatment strategies according to the pathogenesis of NCP,multidisciplinary collaboration,combined therapy with different analgesic drugs and technologies are the therapeutic directions for NCP.